Kansanterveystyö EU:ssa

Improving health systems

Terveyden edistäminen

Medical devices

Substances of human origin

Veri, kudokset ja elimet

Lääkkeet

Tautien torjunta

Riskinarviointi

Tieteelliset komiteat

Endocrine disruptors

Endocrine disruptors

Biocides

Biocides

Tuoreimmat päivitykset

12 tammikuuta 2021

The Impact of Biosimilar Competition in Europe - Annual report conducted by on behalf of the European Commission
05 tammikuuta 2021

Summary record - 91st meeting of the Pharmaceutical Committee (17 November 2020)
14 joulukuuta 2020

Summary record - 90th meeting of the Pharmaceutical Committee (21 October 2020)
25 marraskuuta 2020

Questions and Answers - A Pharmaceutical Strategy for Europe
25 marraskuuta 2020

Press release - Affordable, accessible and safe medicines for all: the Commission presents a Pharmaceutical Strategy for Europe
25 marraskuuta 2020

Impact Assessment - Revision of the EU legislation on medicines for children and rare diseases (25 November 2020 - 06 January 2021)
19 marraskuuta 2020

Deadline for submission of applications prolonged until 4 December 2020 - Independent Scientific experts: Call for expressions of interest for the EMA PRAC Committee
12 marraskuuta 2020

Members representing patients’ organisations: Call for expressions of interest for the EMA COMP Committee
21 lokakuuta 2020

Summary record and documents - 89th meeting of the Pharmaceutical Committee (18-21 September 2020)
21 lokakuuta 2020

Documents - 90th meeting of the Pharmaceutical Committee (21 October 2020)

Pages